Creatinine Measurement Market to Register Substantial Expansion by 2023

(IT-NEWSWIRE.COM, September 18, 2019 ) According to the new market research “Creatinine Measurement Market by Product (Kits, Reagents), Test Type (Jaffe method, Enzymatic creatinine method), Sample (Serum Creatinine, Urine) and End User (Hospitals, Diagnostic Laboratories), Region (North America, Europe) - Global Forecast to 2023", analyzes and studies the major market drivers, restraints/challenges, and opportunities. The global creatinine measurement market is expected to reach USD 564.5 Million by 2023 from USD 349.9 Million in 2017, at a CAGR of 8.4%.

The global Creatinine Measurement market is segmented based on product, test type, sample, end user and regions

The creatinine measurement market, by test type, is segmented into the Jaffe’s kinetic method and enzymatic method. In 2018, the Jaffe’s kinetic method segment is expected to hold the largest share of the creatinine measurement market. The widespread availability and cost-effectiveness of kits and reagents used in Jaffe’s kinetic method is a key factor driving the growth of this market.

Download a PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206847385

Browse and in-depth TOC on in “Creatinine Measurement Market "

96 - Tables

21 - Figures

210 - Pages

Based on type of sample the creatinine measurement market is segmented into blood/serum and urine samples. The blood/serum segment is expected to witness the highest CAGR over the forecast period. Most creatinine measurement kits and reagents are based on the analysis of creatinine in blood samples owing to its accuracy in inferring creatinine concentration and low risk of contamination. These benefits are responsible for the increasing adoption of the blood/serum sample for the measurement of creatinine levels.

Based on end user, the creatinine measurement market is segmented into hospitals and diagnostic laboratories. In 2018, the hospitals segment is expected to account for the largest share of the creatinine measurement owing to established infrastructures with an advanced diagnostic assembly for better diagnostic results within shorter time spans. The diagnostic laboratories segment is expected to witness the highest growth over the forecast period as various market players are entering into long-term collaborations with diagnostic laboratories in order to increase their presence in the creatinine measurement market.

Request Free Sample Report @

https://www.marketsandmarkets.com/requestsampleNew.asp?id=206847385

In 2018, North America is expected to dominate the market followed by Europe. The large share of North America is attributed to factors such as the increasing incidence of renal disorders, rising prevalence of other chronic disorders like hypertension and diabetes (which can lead to renal dysfunction) in the region, and the implementation of favorable government initiatives to increase awareness about kidney diseases and their early diagnosis.

Market Players

The key players in the Creatinine Measurement market are F. Hoffmann-la Roche Ltd (Switzerland)., Abbott Laboratories (US), Danaher Corporation (US), Thermo Fisher Scientific Inc (US), Siemens Healthineers (Germany), Randox Laboratories (UK)., Pointe Scientific, Inc (US), Sentinel Ch. Spa. (Italy), Diasys Diagnostic Systems GmbH (Germany), Dialab GmbH (Vienna), Diazyme Laboratories, Inc (US), Wako Pure Chemical Industries, Ltd. (Japan), Ortho Clinical Diagnostics (US), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).

View Complete Press Release @

https://www.marketsandmarkets.com/PressReleases/creatinine-measurement.asp

MarketsandMarkets™

Mr. Shelly Singh

1-888-600-6441

raviraj.tak@marketsandmarkets.com

Source: EmailWire.Com

Source: EmailWire.com

Technology News & Search Engine

Creatinine Measurement Market to Register Substantial Expansion by 2023